Prematurity
Birth before 37 completed weeks
gestation. 8% of all births. Most prob-lems seen in with infants born <32
completed weeks (72% of all births).
·
Idiopathic
(40%).
·
Previous
preterm birth.
·
Multiple
pregnancy.
·
Maternal
illness, e.g. chorioamnionitis, polyhydramnios, pre-eclampsia, diabetes
mellitus.
·
Premature
rupture of membranes.
·
Uterine
malformation or cervical incompetence.
·
Placental
disease, e.g. dysfunction, antepartum haemorrhage.
·
Poor
maternal health or socio-economic status.
·
Respiratory:
surfactant deficiency causing respiratory distress syndrome, apnoea of
prematurity, chronic lung disease/bronchopulmonary dysplasia (CLD/BPD).
·
CNS: intraventricular haemorrhage,
periventricular leucomalacia; retinopathy
of prematurity.
·
GI: necrotizing enterocolitis;
inability to suck; and poor milk tolerance.
·
Hypothermia.
·
Immuno-compromise
resulting in ‘rise’risk and severity of infection.
·
Impaired
fluid/electrolyte homeostasis (i transepidermal skin water loss, poor renal
function).
·
Patent
ductus arteriosus.
·
Anaemia
of prematurity.
·
Jaundice.
·
Birth
trauma.
·
Perinatal
hypoxia.
·
Later: increased risk of adverse
neurodevelopmental outcome, behavioural
problems, sudden infant death syndrome (SIDS), non-accidental injury (NAI),
and/or parental marriage break up (due to impaired infant–maternal bonding,
stress of long-term complications, etc.).
·
Delivery
should be planned in a centre capable of caring for preterm infants.
·
If a
woman has threatened preterm labour in a centre unable to care for the baby,
possible in-utero transfer should
involve discussion between neonatology and obstetrics teams preferably at
consultant level. Consider foetal fibronectin screening to aid diagnosis and
tocolysis to delay birth to allow for transfer.
·
Give
mother IM corticosteroids, 2 doses, 12–24hr apart, of either beta- or
dexamethasone, if <34wks gestation. Steroids ‘fall’ mortality by up to 40%
(d severity of RDS, periventricular haemorrhage, and necrotizing enterocolitis)
provided they are given >24hr before birth. Benefit persists for at least 7
days. Effect of repeated doses remains unclear—may have adverse impact on later
growth.
·Most preterm infants require
stabilization and support in transition– not
resuscitation.
·Senior paediatrician should be present
at birth if very preterm, e.g. <28wks.
·Delay cord clamping for 1min if
infant not compromised.
·Immediately after birth, place in
food grade plastic bag and under radiant heater.
·Provide respiratory support as
required:
o
use
positive end-expiratory pressure (PEEP) (5cmH2O);
o
start
with lower peak inspiratory pressure or proximal (PIP) (20cmH2O);
o
consider
elective intubation and ETT surfactant if <27/40;
o
may be
possible to stabilize with PEEP/nasal continuous positive airway pressure (CPAP)
only.
·Monitor oxygen saturation levels
if available (right wrist = pre-ductal), and target oxygen therapy
appropriately:
o
must
be familiar with normal values;
o
approx
10% well preterm infants will have SpO2 <70% at 5min;
o
‘correct’
starting dose of O2 unclear, therefore, can start in air;
o
easy
to hyperoxygenate if start in high FiO2.
·Once stable, well infants
>1800g, and >35/40 may be transferred to a suitable postnatal ward if
midwifery staffing and expertise exists for the required additional care. Otherwise
admit to a neonatal unit.
·Measure weight and temperature on
admission and monitor closely:
o
<1000g
37–37.5C;
o
>1000g
36.5–37C;
o
nurse
in 80% humidity for first 7 days if <30/40.
·Monitor and maintain blood glucose
with enteral feeds (expressed breast milk), total parenteral nutrition (TPN) or
10% glucose as appropriate. Encourage ALL mothers to express breast milk from
day 1.
·Start broad spectrum antibiotics
if any possibility of infection, e.g. benzylpenicillin, and gentamicin.
·Start specific treatment for
associated diseases and complications of prematurity, e.g. surfactant for RDS.
·Aim for minimal handling of infant
with appropriate levels of noise and cycled lighting in the nursery.
·
Support
parents.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2026 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.